November 19, 2025
1 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
ORLANDO — In this video from the American Academy of Ophthalmology meeting, David A. Eichenbaum, MD, FASRS, discusses how geographic atrophy remains the most significant unmet need in retina.“We would like therapies that do more, and the good news is we have a robust pipeline of early-stage assets that have a lot of promise,” Eichenbaum, of Retina Vitreous Associates of Florida,
November 19, 2025
1 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

ORLANDO — In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets…

In this video, Anat Loewenstein, MD, MHA, of Tel Aviv Medical Center, Israel, highlights information presented at the American…

LAS VEGAS — In this Healio Video Perspective, Tarek S. Hassan, MD, professor of ophthalmology at Oakland University William…

ORLANDO — In this video from the American Academy of Ophthalmology meeting, Arshad M. Khanani, MD, MA, FASRS, discusses…

DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual…

LAS VEGAS — Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy,…